Jarrow Formulas, Inc.
Records under this name other than the patents Jarrow Formulas, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Showing 1 to 9 of 9 · Back to Jarrow Formulas, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,354,590 | Methods of Producing Edible Fungi Containing Activated Folates and Nutritional Supplements Containing Activated Folates Term ended Term ended May 6, 2025 · High confidence | Term ended | Term ended May 6, 2025 | High confidence |
| US 7,682,606 | Methods of Producing Edible Fungi Containing Activated Folates and Nutritional Supplements Containing Activated Folates Term ended Term ended Sep 9, 2024 · High confidence | Term ended | Term ended Sep 9, 2024 | High confidence |
| US 8,790,723 | Eutectic-Based Self-Nanoemulsified Drug Delivery System Term ended Term ended Nov 14, 2022 · High confidence | Term ended | Term ended Nov 14, 2022 | High confidence |
| US 7,588,786 | Eutectic-Based Self-Nanoemulsified Drug Delivery System Lapsed on the fee record Ended Sep 15, 2021 · High confidence | Lapsed on the fee record | Ended Sep 15, 2021 | High confidence |
| US 8,507,529 | Methods of Using a Nitroxide Antioxidant in Cosmetic and Dermatological Compositions Lapsed on the fee record Ended Aug 13, 2021 · High confidence | Lapsed on the fee record | Ended Aug 13, 2021 | High confidence |
| US 7,553,844 | Methods for treatment of HIV or malaria using combinations of chloroquine and protease inhibitors Lapsed on the fee record Ended Jun 30, 2017 · From the USPTO record | Lapsed on the fee record | Ended Jun 30, 2017 | From the USPTO record |
| US 8,158,162 | Eutectic-Based Self-Nanoemulsified Drug Delivery System Lapsed on the fee record Ended Apr 17, 2016 · High confidence | Lapsed on the fee record | Ended Apr 17, 2016 | High confidence |
| US 8,030,444 | Microbicidal compositions comprising human CD38 polypeptides derived from the extracellular membrane-proximal region Lapsed on the fee record Ended Oct 4, 2015 · From the USPTO record | Lapsed on the fee record | Ended Oct 4, 2015 | From the USPTO record |
| US 6,086,886 | Composition for promoting intestinal health Lapsed on the fee record Ended Jul 11, 2012 · From the USPTO record | Lapsed on the fee record | Ended Jul 11, 2012 | From the USPTO record |